Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial-Reference-Cited by-同舟云学术

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

Published:2019-11 Issue:11 Volume:20 Page:1566-1575
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bisogno Gianni,De Salvo Gian Luca,Bergeron Christophe,Gallego Melcón Soledad,Merks Johannes H,Kelsey Anna,Martelli Helene,Minard-Colin Veronique,Orbach Daniel,Glosli Heidi,Chisholm Julia,Casanova Michela,Zanetti Ilaria,Devalck Christine,Ben-Arush Myriam,Mudry Peter,Ferman Sima,Jenney Meriel,Ferrari Andrea

Funder

French Ministry of Health

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Defining and listing very rare cancers of pediatric age: consensus of the Joint Action on Rare Cancers (JARC) in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT);Ferrari;Eur J Cancer,2019

2. Comparing adult and pediatric rhabdomyosarcoma in the Surveillance, Epidemiology and End Results program, 1973 to 2005: an analysis of 2,600 patients;Sultan;J Clin Oncol,2009

3. Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors;Drummond;Cancer Cell,2018

4. Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned;Arndt;Cancer Treat Rev,2018

5. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group study D9803;Arndt;J Clin Oncol,2009

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ophthalmologic adverse events in childhood head and neck rhabdomyosarcoma survivors treated according to four different local treatment strategies;EJC Paediatric Oncology;2024-12

2. Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management;Computers in Biology and Medicine;2024-09

3. Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board;Cancer;2024-08-25

4. “Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities”;Cancer Letters;2024-08

5. Detoxification and underlying mechanisms towards toxic alkaloids by Traditional Chinese Medicine processing: A comprehensive review;Phytomedicine;2024-07